Stockreport

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 ...

Tenaya Therapeutics, Inc.  (TNYA) 
PDF clinical trial of TN-201 gene therapy for MYBPC3-associated hypertrophic cardiomyopathy on December 17, 2024. The company will host a live webcast and conference call to [Read more]